Skip to main content

Table 3 The relationship between moesin expression and clinicopathological features of LUAD patients

From: Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration

Feature

Moesin

P value

High (n = 18)

Low (n = 72)

Gender

  

P = 0.034

 Male

6 (33.33%)

44 (61.11%)

 

 Female

12 (66.67%)

28 (38.89%)

 

Age at diagnosis

  

P = 0.596

 < 60

9 (50.00%)

31 (43.06%)

 

 ≥ 60

9 (50.00%)

41 (56.94%)

 

Location

  

P = 0.671

 Left

7 (38.89%)

32 (44.44%)

 

 Right

11 (61.11%)

40 (55.56%)

 

T stage

  

P = 0.039

T1–2

11 (61.11%)

60 (83.33%)

 

T3–4

7 (38.89%)

12 (16.67%)

 

N stage

  

P = 0.028

N0

11 (73.33%)

25 (41.67%)

 

N1–3

4 (26.67%)

35 (58.33%)

 

TNM stage

  

P = 0.023

 I

4 (22.22%)

37 (52.11%)

 

 II + III

14 (77.78%)

34 (47.89%)

 

Histological grade

  

P = 0.309

 Well

3 (16.67%)

6 (8.57%)

 

 Moderate

11 (61.11%)

55 (78.57%)

 

 Poor

4 (22.22%)

9 (12.86%)